A genetically modified mouse model probing the selective action of ifenprodil at the N-methyl-d-aspartate type 2B receptor

Molecular and Cellular Neuroscience

Volumn 33, Issue 1, 2006, Pages 47-56

  Rosahl, Thomas W ^a   Wingrove, Peter B ^a   Hunt, Verity ^a   Fradley, Rosa L ^a   Lawrence, Jason M K ^a   Heavens, Robert P ^a   Treacey, Patrick ^a   Usala, Marcelo ^a   Macaulay, Alison ^a   Bonnert, Timothy P ^a   Whiting, Paul J ^a   Wafford, Keith A ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DIZOCILPINE; GLYCINE; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; TRAXOPRODIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DRUG PROTEIN BINDING; EMBRYO; FEMALE; GENE FUNCTION; GENE LOCUS; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VIVO STUDY; LOCOMOTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATCH CLAMP; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GENE TARGETING; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; N-METHYLASPARTATE; NEURONS; PATCH-CLAMP TECHNIQUES; PIPERIDINES; PROTEIN SUBUNITS; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT FUSION PROTEINS; XENOPUS LAEVIS;

MURINAE;

EID: 33747875978     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2006.06.006     Document Type: Article

References (42)

1. Chazot P.L. The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies. Curr. Med. Chem. 11 (2004) 389-396
2. Chen C.A., and Okayama H. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. BioTechniques 6 (1988) 632-638
3. Chenard B.L., Bordner J., Butler T.W., Chambers L.K., Collins M.A., De Costa D.L., Ducat M.F., Dumont M.L., Fox C.B., and Mena E.E. (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-d-aspartate responses. J. Med. Chem. 38 (1995) 3138-3145
4. Cheng Y., and Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
5. 2+ inhibition of the NMDA receptor. Neuron 23 (1999) 171-180
6. Cull-Candy S., Brickley S., and Farrant M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11 (2001) 327-335
7. Dingledine R., Borges K., Bowie D., and Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51 (1999) 7-61
8. Grimwood S., Le Bourdelles B., Atack J.R., Barton C., Cockett W., Cook S.M., Gilbert E., Hutson P.H., McKernan R.M., Myers J., Ragan C.I., Wingrove P.B., and Whiting P.J. Generation and characterization of stable cell lines expressing recombinant human N-methyl-d-aspartate receptor subtypes. J. Neurochem. 66 (1996) 2239-2247
9. Grimwood S., Richards P., Murray F., Harrison N., Wingrove P.B., and Hutson P.H. Characterisation of N-methyl-d-aspartate receptor-specific [(3)H] Ifenprodil binding to recombinant human NR1a/NR2B receptors compared with native receptors in rodent brain membranes. J. Neurochem. 75 (2000) 2455-2463
10. Hatton C.J., and Paoletti P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron 46 (2005) 261-274
11. Hawkins L.M., Chazot P.L., and Stephenson F.A. Biochemical evidence for the co-association of three N-methyl-d-aspartate (NMDA) R2 subunits in recombinant NMDA receptors. J. Biol. Chem. 274 (1999) 27211-27218
12. Kemp J.A., and McKernan R.M. NMDA receptor pathways as drug targets. Nat. Neurosci. 5 (2002) 1039-1042
13. Kiss L., Cheng G., Bednar B., Bednar R.A., Bennett P.B., Kane S.A., McIntyre C.J., McCauley J.A., and Koblan K.S. In vitro characterization of novel NR2B selective NMDA receptor antagonists. Neurochem. Internat. 46 (2005) 453-464
14. + channels. J. Biol. Chem. 272 (1997) 27577-27581
15. Kohr G., Jensen V., Koester H.J., Mihaljevic A.L., Utvik J.K., Kvello A., Ottersen O.P., Seeburg P.H., Sprengel R., and Hvalby O. Intracellular domains of NMDA receptor subtypes are determinants for long-term potentiation induction. J. Neurosci. 23 (2003) 10791-10799
16. Krupp J.J., Vissel B., Heinemann S.F., and Westbrook G.L. N-terminal domains in the NR2 subunit control desensitization of NMDA receptors. Neuron 20 (1998) 317-327
17. Kutsuwada T., Sakimura K., Manabe T., Takayama C., Katakura N., Kushiya E., Natsume R., Watanabe M., Inoue Y., Yagi T., Aizawa S., Arakawa M., Takahashi T., Nakamura Y., Mori H., and Mishina M. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron 16 (1996) 333-344
18. Laube B., Kuhse J., and Betz H. Evidence for a tetrameric structure of recombinant NMDA receptors. J. Neurosci. 18 (1998) 2954-2961
19. Laurie D.J., and Seeburg P.H. Ligand affinities at recombinant N-methyl-d-aspartate receptors depend on subunit composition. Eur.J. Pharmacol. 268 (1994) 335-345
20. Laurie D.J., Bartke I., Schoepfer R., Naujoks K., and Seeburg P.H. Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res. Mol. Brain Res. 51 (1997) 23-32
21. LeBourdelles B., Wafford K.A., Kemp J.A., Marshall G., Bain C., Wilcox A.S., Sikela J.M., and Whiting P.J. Cloning, functional coexpression, and pharmacological characterization of human cDNAs encoding NMDA receptor NR1 and NR2A subunits. J. Neurochem. 62 (1994) 2091-2098
22. Liu L., Wong T.P., Pozza M.F., Lingenhoehl K., Wang Y., Sheng M., Auberson Y.P., and Wang Y.T. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304 (2004) 1021-1024
23. Loscher W., and Honack D. The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur. J. Pharmacol. 215 (1992) 199-208
24. Masuko T., Kashiwagi K., Kuno T., Nguyen N.D., Pahk A.J., Fukuchi J., Igarashi K., and Williams K. A regulatory domain (R1-R2) in the amino terminus of the N-methyl-d-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein. Mol. Pharmacol. 55 (1999) 957-969
25. Mennerick S., and Zorumski C.F. Measurement of glial transport currents in microcultures: application to excitatory neurotransmission. Methods Enzymol. 296 (1998) 632-645
26. Mohrmann R., Kohr G., Hatt H., Sprengel R., and Gottmann K. Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-d-aspartate receptors in nascent neocortical synapses. J. Neurosci. Res. 68 (2002) 265-275
27. Paoletti P., Ascher P., and Neyton J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J. Neurosci. 17 (1997) 5711-5725
28. Paoletti P., Perin-Dureau F., Fayyazuddin A., Le Goff A., Callebaut I., and Neyton J. Molecular organization of a zinc binding n-terminal modulatory domain in a NMDA receptor subunit. Neuron 28 (2000) 911-925
29. Perin-Dureau F., Rachline J., Neyton J., and Paoletti P. Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors. J. Neurosci. 22 (2002) 5955-5965
30. Premkumar L.S., and Auerbach A. Stoichiometry of recombinant N-methyl-d-aspartate receptor channels inferred from single-channel current patterns. J. Gen. Physiol. 110 (1997) 485-502
31. Rachline J., Perin-Dureau F., LeGoff A., Neyton J., and Paoletti P. The micromolar Zinc-binding domain of the NMDA receptor subunit NR2B. J. Neurosci. 25 (2005) 308-317
32. Rosahl T.W., Spillane D., Missler M., Herz J., Selig D.K., Wolff J.R., Hammer R.E., Malenka R.C., and Sudhof T.C. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 375 (1995) 488-493
33. + channels in rat brain. J. Neurosci. 22 (2002) 9698-9707
34. Schwenk F., Baron U., and Rajewsky K.A. cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23 (1995) 5080-5081
35. Tovar K.R., and Westbrook G.L. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J. Neurosci. 19 (1999) 4180-4188
36. Villarroel A., Regalado M.P., and Lerma J. Glycine-independent NMDA receptor desensitization: localization of structural determinants. Neuron 20 (1998) 329-339
37. Wafford K.A., Kathoria M., Bain C.J., Marshall G., LeBourdelles B., Kemp J.A., and Whiting P.J. Identification of amino acids in the N-methyl-d-aspartate receptor NR1 subunit that contribute to the glycine binding site. Mol. Pharm. 47 (1995) 374-380
38. Wang C.X., and Shuaib A. NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Curr. Drug Targets-CNS Neurol. Disorders 4 (2005) 143-151
39. Wenzel A., Fritschy J.M., Mohler H., and Benke D. NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins. J. Neurochem. 68 (1997) 469-478
40. Wingrove P.B., Wafford K.A., Bain C., and Whiting P.J. The modulatory action of loreclezole at the gamma-aminobutyric acid type is determined by a single amino acid in the beta 2 and beta 3 subunit. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4569-4573
41. Wong E., Ng F.M., Yu C.Y., Lim P., Lim L.H., Traynelis S.F., and Low C.M. Expression and characterization of soluble amino-terminal domain of NR2B subunit of N-methyl-d-aspartate receptor. Protein Sci. 14 (2005) 2275-2283
42. Zheng F., Erreger K., Low C.M., Banke T., Lee C.J., Conn P.J., and Traynelis S.F. Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat. Neurosci. 4 (2001) 894-901